SUO 2019

REVIEW UroToday

Viewing 1-20 of 59 articles

SUO 2019: MRI for Staging for Bladder Cancer & ViRads System

SUO 2019: Active Surveillance versus Office Fulguration or Laser Treatment

SUO 2019: En Bloc Resection

SUO 2019: Serum microRNA-371a-3p Levels Predict Viable Germ Cell Tumor in Chemotherapy-Naïve Patients Undergoing Retroperitoneal Lymph Node Dissection

SUO 2019: Immunotherapy in Bladder Cancer: Targets and Surgical Timing

SUO 2019: Transperineal Versus Transrectal Ultrasound-Guided Systematic Biopsy: Understanding the True Costs Utilizing Time-Driven Activity-Based Costing

SUO 2019: Evaluating Transurethral Resection of Bladder Tumor (TURBT) Quality

SUO 2019: Evaluation of Biomarkers 4K Score, SelectMDx and ExoDx™, PSAD, TRUS and MRI for the Detection of High-Grade Prostate Cancer

SUO 2019: Characterization of 68GA-PSMA and 18F-Fluciclovine (Axumin®) Transporter Gene Expression in Localized Prostate Cancer

SUO 2019: Better Outcomes at Higher Volume Centers: Evaluating Your Institution’s Data

SUO 2019: Risk of Multiple Levels of Recurrence and Progression after Initial Diagnosis of Non-Muscle Invasive Bladder Cancer in a Multi-Site, Community-Based Cohort

SUO 2019: Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in High Grade Nonmuscle Invasive Bladder Cancer

SUO 2019: My Active Surveillance Trajectory: A Literary Bibliography - Laurence Klotz

SUO 2019: Update on Adjuvant Trials and the CTC

SUO 2019: Radiotherapy after Radical Prostatectomy: Effect of Timing of Post-Prostatectomy Radiation on Functional Outcomes

SUO 2019: How to Improve Uro-Oncological Surgery with Intraoperative Real-Time Multisensory Technology

SUO 2019: Heterogeneity in Policy Effect: Changes in Prostate Cancer Screening Associated with ACO Participation

SUO 2019: The Role of Radiation in the Management of Renal Cell Carcinoma

SUO 2019: 2019 Richard D. Williams, MD Prostate Cancer Research Excellence Award Lecture: Prostate Cancer Screening

SUO 2019: Genomic Umbrella Neoadjuvant Study and other Biomarker Trials

1
2
3